Physician profile
Walter Rustmann
NPI 1235116054
$2,921.43
in general payments reported to CMS, 2019-2025
26 companies · $550 in 2025
The $550 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $257 · 2021: $321 · 2022: $495 · 2023: $433 · 2024: $643 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $766.28 | 2019-2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.54 | 2019-2024 | Ofev |
| Glaxosmithkline, LLC. | $250.08 | 2019-2025 | Trelegy Ellipta, Nucala |
| Jazz Pharmaceuticals INC. | $212.50 | 2023-2025 | |
| Grifols USA, LLC | $136.92 | 2020-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $130.01 | 2020-2025 | |
| Pinnacle Biologics, INC | $126.20 | 2022 | |
| Lilly USA, LLC | $105.96 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $102.27 | 2019-2024 | Airsupra, Tezspire |
| Edwards Lifesciences Corporation | $97.21 | 2020-2023 | Hemosphere |
| Philips North America LLC | $90.03 | 2019-2025 | Vest Therapy Und |
| Amgen INC. | $79.40 | 2022-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $73.92 | 2022-2025 | Dupixent |
| Verona Pharma, INC. | $61.64 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $50.86 | 2019-2024 | Yupelri |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $48.44 | 2024-2025 | Arikayce |
| Harmony Biosciences LLC | $35.56 | 2020-2023 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $31.90 | 2025 | Lumryz |
| United Therapeutics Corporation | $28.76 | 2024 | Tyvaso |
| Baxter Healthcare | $21.18 | 2023 | Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $20.44 | 2025 | Glassia |
| Viatris Specialty LLC | $17.83 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $16.27 | 2023 | Sunosi |
| Inogen, INC. | $15.72 | 2022 | |
| Resmed Corp | $13.75 | 2024 | |
| Fisher & Paykel Healthcare INC | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Rustmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.